Results 221 to 230 of about 1,144,647 (289)
Data-driven identification of core tumor-secreted factors associated with cachexia prevalence. [PDF]
Cury SS, Freire PP, Carvalho RF.
europepmc +1 more source
FPD‐GELNs co‐deliver Su and bioactive components. This active‐passive dual‐targeting strategy suppresses the progression of RCC through the following mechanisms: 1) inhibition of the PI3K‐Akt signaling pathway; 2) downregulation of ABCB1/P‐gp to enhance the chemosensitivity of RCC to Su; and 3) reprogramming of macrophages toward M1 polarization and ...
Haoyu Xu +8 more
wiley +1 more source
Antibody-Mediated In Vitro Activation and Expansion of Blood Donor-Derived Natural Killer Cells with Transient Anti-Tumor Efficacy. [PDF]
Luo S +12 more
europepmc +1 more source
Tumor evolution in lung adenocarcinoma is shaped by genetic alterations and spatial immune dynamics. By integrating whole‐exome sequencing, imaging mass cytometry, and spatial transcriptomics across two mouse models, this study reveals how mutational burden, immune infiltration, and cell–state interactions evolve during early and late carcinogenesis ...
Bo Zhu +34 more
wiley +1 more source
PBRM1 ranks as the second most commonly mutated gene in ccRCC. This study reveals that PBRM1 loss promotes an immunosuppressive microenvironment by elevating M2 TAMs via the KDM5C–IL‐6 axis. These M2 TAMs, along with CAFs, form a barrier that excludes CD8+ T cells. Targeting IL‐6 synergizes with anti‐PD1 therapy, offering a promising strategy for PBRM1‐
Wenjiao Xia +14 more
wiley +1 more source
Skin-lung axis in the atopic march: The immune link from skin to lungs. [PDF]
Zhu M, Liu X, Jing Q, Yao L, Yao X.
europepmc +1 more source
Immune repertoire profiling and T cell dysregulation in Peripheral Blood Mononuclear Cells of Type 2 diabetic patients. [PDF]
Bi Z, Wang F, Wang S, Fang Z.
europepmc +1 more source
Precision Medicine in Asthma: The Role of Biomarkers. [PDF]
Quek E, Horn N, Siddiqui S.
europepmc +1 more source
The Dual Role of Myokines in Fatigue Associated with Inflammatory Joint Diseases. [PDF]
Chmielewski G +6 more
europepmc +1 more source

